News Summary: Pfizer 1Q profit up, forecast down

Published



THE RESULTS: Drugmaker Pfizer’s results for the first quarter missed analysts’ expectations, as generic competition cut sales by 9 percent to $13.5 billion. Net income jumped 53 percent, but only because of a one-time gain in the quarter and big charges a year earlier.

THE REACTION: Between the weak results and Pfizer lowering its profit and revenue forecast for the year, investors drove down shares by an unusually steep 4.5 percent.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.